Unique ID issued by UMIN | UMIN000026589 |
---|---|
Receipt number | R000030532 |
Scientific Title | Dose-finding study of drink-A containing lactic acid bacteria |
Date of disclosure of the study information | 2017/03/24 |
Last modified on | 2017/10/13 15:29:35 |
Dose-finding study of drink-A containing lactic acid bacteria
Dose-finding study of drink-A containing lactic acid bacteria
Dose-finding study of drink-A containing lactic acid bacteria
Dose-finding study of drink-A containing lactic acid bacteria
Japan |
Subjects who have a tendency to be constipated
Not applicable |
Others
NO
Calculation of effective dose of the drink containing Lactobacillus casei NY1301 on bowel movement of subjects who have a tendency to be constipated.
Safety,Efficacy
Defecation frequency, fecal amount
Fecal shape, fecal color, feelings after defecation, analysis of intestinal microflora
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
Intake of drink containing high-dose lactic acid bacteria for 2 weeks
Intake of drink containing low-dose lactic acid bacteria for 2 weeks
Intake of placebo drink for 2 weeks
20 | years-old | <= |
70 | years-old | > |
Male and Female
(1)Males and females from 20 to 70 years-old
(2)Subjects who have a tendency to be constipated defecate two to five times a week
(3)Subjects undergoing none of medical treatments
(4)Subjects eat regular
(1)Males and females from 20 to 70 years-old
(2)Subjects who have a tendency to be constipated defecate two to five times a week
(3)Subjects undergoing none of medical treatments
(4)Subjects eat regularly
(1)Subjects with a serious disease
(2)Subjects have a medical history or a surgical history of digestive diseases
(3)Subjects allergic to a specific drug or food
(4)Subjects work alternative or midnight shifts
(5)Subjects never be able to stop intaking foods or drinks which improve constipation during study,such as foods containing lactic acid bacteria, bifidobacteria, natto bacteria, oligosaccharides, dietary fibers and/or other health foods including food for specified health use
(6)Subjects who have any kinds of drugs affect this study (constipation drugs, intestinal drugs, etc.)
(7)Subjects drink alcohol over 500mL in terms of beer per day
(8)Subjects smoke over 20 cigarettes per day
(9)Subjects drawn blood over 200mL last 1 month, or over 400mL last 3 months
(10)Subjects allergic to samples in this study
(11)Pregnants, lactating women or who is going to be pregnant
(12)Subjects who have participated in the other clinical studies
(13)Subjects judged as unsuitable for the study by the principal investigator for other reasons
40
1st name | |
Middle name | |
Last name | Hiroshi Moriyama |
Kanazawabunko Hospital
Vice president
2-6-22,Kamariyahigashi,Kanazawa-ku, Yokohama city,Kanagawa,Japan
045-785-3311
nagashima@kanabun-hp.jp
1st name | |
Middle name | |
Last name | Soichi Yoneda |
QOL RD Co.,Ltd.
CRO Department Food Division
2-14-1,Nihonbashi,Chuo-ku,Tokyo,Japan
03-6386-8809
s-yoneda@qol-rd.co.jp
QOL RD Co.,Ltd.
Nissin york Co.,Ltd.
Profit organization
NO
金沢文庫病院(神奈川県)、上尾甦生病院(埼玉県)、白岡中央総合病院(埼玉県)、さがみリハビリテーション病院(神奈川県)、メディカルトピア草加病院(埼玉県)、桜ヶ丘中央病院(神奈川県)、横浜なみきリハビリテーション病院(神奈川県)、浅草病院(東京都)、武蔵境クリニック(東京都)、日本橋ハートクリニック(東京都)、八木病院(東京都)
2017 | Year | 03 | Month | 24 | Day |
Unpublished
Completed
2016 | Year | 12 | Month | 20 | Day |
2017 | Year | 03 | Month | 29 | Day |
2017 | Year | 03 | Month | 17 | Day |
2017 | Year | 10 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030532